Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical furosemide versus potassium hydroxide gel for non-genital warts
IRCT20120524009844N9Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of furosemide and potassium hydroxide in verruca, sponsored by Tabriz University of Medical Sciences. Primary endpoints: Number of warts, Wart diameter and 2 more. Started May 2021; status: completed.
02
Drugs
furosemidepotassium hydroxide
03
Conditions
verruca
Beyond the preview
Go deeper on IRCT20120524009844N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120524009844N9.